期刊
BEHAVIOURAL PHARMACOLOGY
卷 33, 期 2-3, 页码 90-104出版社
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/FBP.0000000000000621
关键词
addiction; cannabinoids; conditioned place preference; drug abuse; memory; reward
资金
- Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES) [001']
- Brazilian National Council for Scientific and Technological Development (CNPq)
- CNPq
- 'Fundacao de Amparo a Pesquisa do Estado de Minas Gerais' (FAPEMIG) [APQ-02064-15]
- 'Fundacao de Amparo a Pesquisa do Estado de Sao Paulo' (FAPESP) [2017/24304-0]
- Instituto Nacional de Ciencia e Tecnologia Translacional em Medicina (INCTTranslational Medicine)
This review examines the effects of cannabinoids in place conditioning and the therapeutic potential of the endocannabinoid system in interfering with drug-related memories. The study finds that synthetic CB1 receptor agonists replicate the biphasic profile observed with THC, while CB2 receptor agonists inhibit cocaine-induced conditioned place preference. However, the therapeutic use of these compounds is limited by potential psychiatric side effects.
Drug abuse and addiction can be initiated and reinstated by contextual stimuli previously paired with the drug use. The influence exerted by the context on drug-seeking behaviour can be modelled in experimental animals with place-conditioning protocols. Here, we review the effects of cannabinoids in place conditioning and the therapeutic potential of the endocannabinoid system for interfering with drug-related memories. The phytocannabinoid Delta(9)-tetrahydrocannabinol (THC) tends to induce conditioned place preference (CPP) at low doses and conditioned place aversion at high doses; cannabidiol is devoid of any effect, yet it inhibits CPP induced by some drugs. Synthetic CB1 receptor agonists tend to recapitulate the biphasic profile observed with THC, whereas selective antagonists/inverse agonists inhibit CPP induced by cocaine, nicotine, alcohol and opioids. However, their therapeutic use is limited by potential psychiatric side effects. The CB2 receptor has also attracted attention, because selective CB2 receptor agonists inhibit cocaine-induced CPP. Inhibitors of endocannabinoid membrane transport and hydrolysis yield mixed results. In targeting the endocannabinoid system for developing new treatments for drug addiction, future research should focus on 'neutral' CB1 receptor antagonists and CB2 receptor agonists. Such compounds may offer a well-tolerated pharmacological profile and curb addiction by preventing drug-seeking triggered by conditioned contextual cues. Copyright (C) 2021 Wolters Kluwer Health, Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据